NOD2 downregulates colonic inflammation by IRF4-mediated inhibition of K63-linked polyubiquitination of RICK and

T Watanabe1, N Asano2, G Meng3

  • 11] Center for Innovation in Immunoregulative Technology and Therapeutics, Kyoto University Graduate School of Medicine, Kyoto, Japan [2] Mucosal Immunity Section, Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA [3] Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Mucosal Immunology
|March 28, 2014
PubMed

Insights

Genetic variations in CARD15 increase Crohn's disease risk by impairing NOD2 function. This study reveals NOD2 activation regulates immune responses via IRF4, impacting NF-κB signaling and potentially explaining CD susceptibility.

Area of Science:

  • Immunology
  • Genetics
  • Gastroenterology

Background:

  • Polymorphisms in the CARD15 gene are a significant risk factor for Crohn's disease (CD), leading to impaired NOD2 function.
  • The precise molecular mechanisms linking NOD2 dysfunction to increased CD susceptibility remain incompletely understood.
  • Previous work indicated NOD2 activation negatively regulates TLR-mediated inflammation in dendritic cells.

Purpose of the Study:

  • To elucidate the molecular mechanism by which NOD2 dysfunction contributes to Crohn's disease pathogenesis.
  • To define the role of interferon regulatory factor 4 (IRF4) in NOD2-mediated immune regulation.
  • To investigate the impact of NOD2 activation on inflammatory signaling pathways relevant to CD.

Main Methods:

  • Investigated NOD2 activation by muramyl dipeptide (MDP) in human dendritic cells.
  • Analyzed the interaction of NOD2-activated IRF4 with TRAF6 and RICK.
  • Assessed the effect of IRF4 on Lys63-linked polyubiquitination of TRAF6 and RICK, and subsequent NF-κB activation.
  • Utilized a mouse model of experimental colitis to evaluate the therapeutic potential of MDP or IRF4.

Main Results:

  • NOD2 activation leads to increased IRF4 expression, which binds to TRAF6 and RICK.
  • This binding inhibits Lys63-linked polyubiquitination of TRAF6 and RICK, downregulating NF-κB activation.
  • Administration of MDP or IRF4 protected mice from experimental colitis, associated with similar IRF4-mediated effects on TRAF6/RICK polyubiquitination in colonic cells.

Conclusions:

  • NOD2 activation regulates innate immune responses to gut microbiota through an IRF4-dependent mechanism.
  • This pathway involves the modulation of TRAF6 and RICK polyubiquitination, impacting NF-κB signaling.
  • Findings provide a molecular explanation for how CARD15 polymorphisms and NOD2 dysfunction increase Crohn's disease risk.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.0K